Welcome to our dedicated page for WW INTERNATIONAL SEC filings (Ticker: WW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
WW International, Inc.'s SEC filings document the regulatory record for Weight Watchers' subscription-based weight-management and clinical businesses. Recent Forms 8-K furnish quarterly results, shareholder letters, Regulation FD disclosures about term-loan prepayment actions, and material governance events involving directors, board committees and interim executive officers.
The company's proxy materials cover annual-meeting voting matters, director elections, board independence, committee service and non-employee director compensation. Its filings also identify WW common stock, no par value, registered on the Nasdaq Stock Market and provide formal disclosure of capital-structure, compensation and corporate-governance matters.
The Vanguard Group filed Amendment No. 7 to a Schedule 13G/A reporting 0 shares of common stock of WW International Inc. The filing notes an internal realignment effective January 12, 2026 that caused certain Vanguard subsidiaries and business divisions to report beneficial ownership separately. The filing shows amount beneficially owned: 0 and percent of class: 0%. The form is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
WW International, Inc. Schedule 13G shows that Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander report shared beneficial ownership of 591,173 shares of common stock, representing 5.9% of the class as reported on the cover pages.
The filing is a joint filing executed and signed on 03/18/2026 and includes a Joint Filing Agreement among the three filers.
WW International, Inc. reports its annual results and outlines a major post‑bankruptcy reset. The company emerged from Chapter 11 on June 24, 2025, discharging approximately $1,116.0 million of prepetition credit facilities and $500.0 million of senior secured notes. It put in place a new $465.0 million senior secured term loan maturing in 2030 and applied fresh start accounting, creating separate Successor and Predecessor periods.
WW now operates as a single reportable segment built around two main lines: a “Behavioral” subscription business and a U.S. “Clinical” Med+ telehealth offering centered on GLP‑1 and related weight‑management medications. As of the end of fiscal 2025, it had about 2.6 million Behavioral subscribers and 130.2 thousand Clinical subscribers
WW International reported mixed fourth quarter and full-year 2025 results as it transitions from a traditional behavioral weight-loss model to an integrated clinical and GLP-1 focused platform. Q4 2025 total revenue was $163 million, down 12% year-over-year, with behavioral subscription revenue falling 17% while clinical subscription revenue grew 32% to $27 million. The company posted a Q4 net loss of $6 million, a net loss margin of 3.6%, and Adjusted EBITDA of $18 million with an 11.1% margin, down from $46 million and a 25.1% margin a year earlier.
Management highlighted strong momentum in its clinical Med+ offering and GLP-1 Success Program, noting end-of-period clinical subscribers rose 42% to 130,000 within a total subscriber base of 2.8 million. For 2026, WW guided to revenue of $620–$635 million and Adjusted EBITDA of $105–$115 million, and estimated first quarter 2026 end-of-period subscribers of about 2.65 million, including roughly 200,000 clinical subscribers. Following its June 2025 Chapter 11 reorganization, WW ended 2025 with $160 million of cash and a significantly reduced term loan of $465 million, cutting total debt by more than 70% from $1.6 billion and improving net debt to about $305 million.
Cooper Creek Partners Management LLC has disclosed a significant stake in WW International, Inc. As of December 31, 2025, the firm reports beneficial ownership of 649,985 shares of WW International common stock, representing 6.5% of the outstanding class.
Cooper Creek reports sole voting and sole dispositive power over all 649,985 shares, with no shared power. The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of WW International, indicating a passive investment stance.
WW International director Julie Bornstein reported acquiring 1,166 shares of WW International, Inc. common stock on 01/02/2026. The transaction was coded "A" and priced at $0.00 per share, indicating an award rather than an open‑market purchase. Following this grant, she beneficially owns 2,918 shares of common stock in direct ownership. According to the accompanying note, these shares are subject to transfer restrictions, meaning they cannot be freely sold or transferred until specified conditions are met.
WW International director Michael B. Mason reported acquiring 1,166 shares of common stock on 01/02/2026 at a price of $0.00 per share. After this transaction, he beneficially owned 2,385 shares in total, held directly.
According to the footnote, these shares are subject to transfer restrictions, meaning they cannot be freely sold or transferred until certain conditions are met. The filing reflects a change in Mason's ownership position as a director of WW International, Inc. (ticker WW).
WW International director Eugene I. Davis reported an acquisition of derivative equity awards in the form of deferred stock units. On January 2, 2026, he received 1,166 Deferred Stock Units at a price of $0.00 per unit, increasing his beneficial holdings in these derivatives to 2,385 Deferred Stock Units.
Each Deferred Stock Unit represents the right to receive one share of WW International common stock upon settlement. According to his prior election under the company’s deferred compensation program for non-employee directors, these units will be settled into common shares on the date he separates from service on the company’s board of directors.
WW International, Inc. (WW) filed an initial Form 3 for executive Nina Ann George, who serves as Chief Marketing & CS Officer. The filing states in the remarks section that no securities are beneficially owned. The form is filed on behalf of Nina Ann George by an attorney-in-fact under a Limited Power of Attorney.
WW International, Inc. (WW) director Carney Hawks reported open-market purchases of common stock. On 11/19/2025, the director bought 20,000 shares of WW common stock at a price of $22.75 per share and an additional 9,057 shares at a weighted average price of $20.8087 per share. The weighted average reflects multiple trades executed between $20.67 and $20.85. Following these transactions, the director beneficially owns 29,057 shares of WW common stock directly.